-
Exclusive: Cytosorbents CEO On How Its Blood Purification Technology Can Change Healthcare
Monday, August 15, 2016 - 8:54am | 611Cytosorbents Corp (NASDAQ: CTSO) is a critical care focused immunotherapy company that focuses on the commercializing its main product, CytoSorb - a blood purification technology which focuses on preventing or treating multiple organ failures. Benzinga had the opportunity to chat with the...